ArticleIJID regions2025
Access to plasma viral load in people living with HIV under treatment in Ouagadougou and Bobo Dioulasso, Burkina Faso.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Less than 25% of people living with HIV (PLWHIV) achieved plasma viral load (PVL) in 2020 in Burkina Faso. This study aimed to identify factors associated with access to PVL in Ouagadougou and Bobo-Dioulasso. Methods: A cross-sectional analytical study was conducted among PLWHIV in Burkina Faso between April 15 and August 8, 2022. The proportion of PLWHIV with PVL after at least 6 months of treatment was calculated, and the associated factors were determined by logistic regression. Results: A total of 308 PLWHIV were included in the study; 64.9% (95% confidence interval [CI] 58.3-71.5) of PLWHIVs had PVL, 66.2% (95% CI 52.1-80.3) among men. Therapeutic education on the importance of PVL was associated with a 1.79-fold increase in the chance of achieving PVL (adjusted odds ratio [ORa] 2.32, 95% CI 1.42-3.78, Conclusions: Access to PVL is not optimal in Burkina Faso. Efforts must therefore be made to strengthen therapeutic education for PLWHIV and mobilize more associations in favor of this essential examination for the follow-up of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.